cephalosporin c has been researched along with cefovecin in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (25.00) | 29.6817 |
| 2010's | 23 (63.89) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchflower, S; Sherington, J; Stegemann, MR | 1 |
| Blanchflower, S; Brown, SA; Coati, N; Sherington, J; Stegemann, MR | 1 |
| Passmore, CA; Sherington, J; Stegemann, MR | 2 |
| Coati, N; Passmore, CA; Sherington, J; Stegemann, MR | 1 |
| Passmore, C; Sherington, J; Stegemann, MR | 1 |
| Boucher, JF; Cherni, J; Chesebrough, R; Cleaver, D; Lindeman, CJ; Papp, G; Six, R; Skogerboe, TL; Stegemann, MR; Weigel, DJ | 1 |
| Boucher, JF; Cherni, J; Chesebrough, R; Cleaver, DM; Lindeman, CJ; Papp, G; Six, R; Skogerboe, TL; Stegemann, MR; Weigel, DJ | 1 |
| Bertelsen, MF; Brimer, L; Skaanild, MT; Thuesen, LR | 1 |
| Kelly, N; Papp, R; Popovic, A; Tschirret-Guth, R | 1 |
| Bakker, J; Bertelsen, MF; Braskamp, G; Langermans, JA; Ouwerling, B; Skaanild, MT; Thuesen, LR | 1 |
| Boucher, JF; Brown, SA; Civil, JR; Fortman, JD; Gillhouse, KA; Grover, GS; Halliday, LC; Hoggatt, AF; Lovaglio, J; Raabe, BM; Stubbs, MN; Yuan, Y | 1 |
| Constable, PD; Litster, AL; Wu, CC | 1 |
| Schumacher, J; Seibert, R; Steeil, J; Tobias, K | 1 |
| Ide, K; Iwasaki, T; Iyori, K; Nishifuji, K; Toyoda, Y | 1 |
| Coetzee, JF; Grauer, G; Heinrich, E; Kukanich, B; Kukanich, K; Lawrence, M; Narayanan, S | 1 |
| Cox, S; Hamill, M; Martin, A; Pistole, N; Schumacher, J; Steeil, J | 1 |
| Bird, PS; Khazandi, M; Meyer, JN; Owens, J; Trott, DJ; Wilson, G | 1 |
| Baine, K; Bulman, F; Cox, S; George, RH; Schumacher, J; Steeil, JC | 1 |
| Barbarossa, A; Bielli, M; Cagnardi, P; Dall'Occo, A; Di Girolamo, N; Magnone, W; Nardini, G; Roncada, P; Zaghini, A | 1 |
| Cox, S; Doherty, T; Hamill, M; Hayes, J; Pistole, N; Seddighi, R; Sommardahl, C; Videla, R | 1 |
| Garcia-Tapia, D; Hardham, JM; Heinz, TJ; Honsberger, N; Johnson, J; King, V; Marconi, RT; Meeus, PF; Strietzel, C; Wagner, B | 1 |
| Álvaro, T; Encinas, T; García-Párraga, D; García-Peña, FJ; Gilabert, JA; Ros-Rodríguez, JM; Valls, M | 1 |
| Bishop, MA; KuKanich, B; Seeley, KE; Turnquist, M; Wolf, KN | 1 |
| Encinas, T; López-SanRoman, J; Pérez-Nogués, M | 1 |
| Blondeau, JM; Shebelski, SD | 1 |
| Black, V; Burke, S; Hibbert, A; Radford, A; Sánchez-Vizcaíno, F; Tasker, S | 1 |
| Bas, E; Cox, SK; Rothen, DE; Sanders, KL | 1 |
| Cox, S; Cushing, AC; Ramsay, EC; Steeil, J | 1 |
| Dudek, A; Gołyńska, M; Matuszewski, Ł; Polkowska, I; Sobczyńska-Rak, A; Szponder, T; Żylińska, B | 1 |
| Alshahrani, SM; Christensen, JM; Flaminio, KP; Mohammed, SM | 1 |
| Gharibi, S; Govendir, M; Vogelnest, L | 1 |
| Bailey, KE; Baldwin, T; Billman-Jacobe, H; Browning, GF; Gilkerson, J; Hardefeldt, L; Hur, B; Richards, S; Scarborough, R; Verspoor, K | 1 |
| Crosier, A; Emerson, J; Garcés Torres, R; Helmick, K; Kinney, ME; Murray, S; Papich, MG; Sanchez, CR; Yu, JH | 1 |
| Calle, PP; Moore, RP; Papich, MG; Paré, J; Raphael, BL; Sykes, JM; Valitutto, MT; Yu, JH | 1 |
| Cazer, CL; Frye, A; Gonzalez, L; Lawless, JW; Safi, AG | 1 |
1 review(s) available for cephalosporin c and cefovecin
| Article | Year |
|---|---|
CEFOVECIN PROTEIN BINDING AS A PREDICTOR FOR EXTENDED DURATION OF ACTION: A REVIEW OF CURRENT LITERATURE AND IN VITRO ANALYSIS IN MULTIPLE ZOOLOGICAL SPECIES.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Dog Diseases; Dogs; Injections, Subcutaneous; Protein Binding | 2021 |
15 trial(s) available for cephalosporin c and cefovecin
| Article | Year |
|---|---|
Efficacy and safety of cefovecin (Convenia) for the treatment of urinary tract infections in dogs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cephalosporins; Dog Diseases; Dogs; Double-Blind Method; Escherichia coli Infections; Europe; Female; Injections, Subcutaneous; Male; Treatment Outcome; Urinary Tract Infections | 2007 |
Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections.
Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Male; Pyoderma; Treatment Outcome; Wound Infection | 2007 |
The efficacy and safety of cefovecin in the treatment of feline abscesses and infected wounds.
Topics: Abscess; Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Clavulanic Acid; Europe; Female; Injections, Subcutaneous; Male; Treatment Outcome; Wound Infection | 2007 |
Efficacy and safety of cefovecin for the treatment of urinary tract infections in cats.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Double-Blind Method; Escherichia coli Infections; Female; Injections, Subcutaneous; Male; Safety; Treatment Outcome; Urinary Tract Infections | 2008 |
Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs.
Topics: Abscess; Animals; Anti-Bacterial Agents; Cefadroxil; Cephalosporins; Dog Diseases; Dogs; Female; Folliculitis; Male; Safety; Treatment Outcome; Wound Infection | 2008 |
Effectiveness and safety of cefovecin sodium, an extended-spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected wounds.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Male; Microbial Sensitivity Tests; Safety; Treatment Outcome; Wound Infection | 2009 |
Selected pharmacokinetic parameters for Cefovecin in hens and green iguanas.
Topics: Animals; Anti-Bacterial Agents; Birds; Cephalosporins; Female; Molecular Structure; Reptiles; Species Specificity | 2009 |
Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Doxycycline; Drug Administration Schedule; Female; Housing, Animal; Male; Respiratory Tract Infections | 2012 |
Effect of cefovecin on the fecal flora of healthy dogs.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chromatography, Liquid; Colony Count, Microbial; Dogs; Drug Resistance, Bacterial; Enterococcus; Escherichia coli; Feces; Female; Male; Mass Spectrometry; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Salmonella; Time Factors | 2013 |
Pharmacokinetics of cefovecin sodium after subcutaneous administration to Hermann's tortoises (Testudo hermanni).
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Female; Injections, Subcutaneous; Male; Turtles | 2014 |
Pharmacokinetics of intravenous and subcutaneous cefovecin in alpacas.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Camelids, New World; Cephalosporins; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Male | 2015 |
Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs.
Topics: Amoxicillin; Animals; Borrelia burgdorferi; Cephalosporins; Dog Diseases; Dogs; Doxycycline; Lyme Disease; Pilot Projects | 2015 |
Pharmacokinetics of Single-bolus Subcutaneous Cefovecin in C57BL/6 Mice.
Topics: Animals; Animals, Laboratory; Anti-Bacterial Agents; Cats; Cephalosporins; Dogs; Half-Life; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL | 2017 |
PHARMACOKINETIC PARAMETERS OF CEFOVECIN SODIUM (CONVENIA) IN CAPTIVE TIGERS ( PANTHERA TIGRIS).
Topics: Animals; Animals, Zoo; Anti-Bacterial Agents; Cephalosporins; Female; Male; Random Allocation; Tigers | 2017 |
Pharmacokinetics after subcutaneous administration of a single dose of cefovecin sodium in African lions (Panthera leo).
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Cats; Cephalosporins; Cross-Over Studies; Female; Half-Life; Lions; Male; Microbial Sensitivity Tests | 2019 |
20 other study(ies) available for cephalosporin c and cefovecin
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of cefovecin in dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Cross-Over Studies; Dogs; Female; Infusions, Intravenous; Injections, Subcutaneous; Male; Microbial Sensitivity Tests; Staphylococcus | 2006 |
Pharmacokinetics of cefovecin in cats.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cats; Cephalosporins; Cross-Over Studies; Female; Infusions, Intravenous; Injections, Subcutaneous; Male; Microbial Sensitivity Tests; Pasteurella multocida | 2006 |
Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis).
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Dog Diseases; Dogs; Half-Life; Injections, Subcutaneous; Macaca fascicularis; Macaca mulatta; Male; Saimiri; Skin Diseases, Bacterial; Species Specificity | 2010 |
Single subcutaneous dosing of cefovecin in rhesus monkeys (Macaca mulatta): a pharmacokinetic study.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cephalosporins; Female; Half-Life; Injections, Subcutaneous; Macaca mulatta; Male; Microbial Sensitivity Tests | 2011 |
Pharmacokinetics of cefovecin in cynomolgus macaques (Macaca fascicularis), olive baboons (Papio anubis), and rhesus macaques (Macaca mulatta).
Topics: Animals; Animals, Laboratory; Anti-Infective Agents; Cephalosporins; Female; Glomerular Filtration Rate; Half-Life; Macaca fascicularis; Macaca mulatta; Male; Monkey Diseases; Papio anubis; Skin Diseases; Species Specificity | 2011 |
Cefovecin (Convenia) for the treatment of septic peritonitis in a female lion (Panthera leo).
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cephalosporins; Female; Hysterectomy; Lions; Meloxicam; Pain; Peritonitis; Pyometra; Sepsis; Thiazines; Thiazoles | 2012 |
Usefulness of cefovecin disk-diffusion test for predicting mecA gene-containing strains of Staphylococcus pseudintermedius and clinical efficacy of cefovecin in dogs with superficial pyoderma.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Disk Diffusion Antimicrobial Tests; Dog Diseases; Dogs; Female; Gene Expression Regulation, Bacterial; Male; Microbial Sensitivity Tests; Pyoderma; Staphylococcal Skin Infections; Staphylococcus | 2013 |
Development of a method for the determination of cefovecin in plasma by HPLC.
Topics: Animals; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Horseshoe Crabs; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Sharks; Solid Phase Extraction; Spectrophotometry, Ultraviolet | 2014 |
In vitro efficacy of cefovecin against anaerobic bacteria isolated from subgingival plaque of dogs and cats with periodontal disease.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Cat Diseases; Cats; Cephalosporins; Dental Plaque; DNA, Bacterial; DNA, Ribosomal; Dog Diseases; Dogs; Microbial Sensitivity Tests; Periodontal Diseases; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2014 |
Pharmacokinetics of cefovecin (Convenia) in white bamboo sharks (Chiloscyllium plagiosum) and Atlantic horseshoe crabs (Limulus polyphemus).
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Half-Life; Horseshoe Crabs; Protein Binding; Sharks | 2014 |
Long-lasting concentrations of cefovecin after subcutaneous and intramuscular administration to Patagonian sea lions (Otaria flavescens).
Topics: Animals; Animals, Zoo; Anti-Bacterial Agents; Cephalosporins; Dose-Response Relationship, Drug; Female; Half-Life; Injections, Intramuscular; Injections, Subcutaneous; Male; Sea Lions | 2016 |
Pharmacokinetics of long-acting cefovecin in copper rockfish (Sebastes caurinus).
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Compounding; Fishes; Half-Life; Protein Binding | 2016 |
Pharmacokinetics and local tolerance of cefovecin sodium after intra-articular administration in horses.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Cephalosporins; Drug Tolerance; Female; Horse Diseases; Horses; Injections, Intra-Articular; Joints; Male | 2017 |
Comparative in vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefovecin, cefazolin, doxycycline and pradofloxacin.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Dogs; Doxycycline; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Staphylococcus | 2016 |
Use of cefovecin in a UK population of cats attending first-opinion practices as recorded in electronic health records.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Cat Diseases; Cats; Cephalosporins; Databases, Factual; Female; Male; Practice Patterns, Physicians'; United Kingdom; Veterinary Drugs | 2017 |
Haptoglobin as a treatment monitoring factor in feline plasmacytic gingivostomatitis.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Cat Diseases; Cats; Cephalosporins; Dental Care; Female; Gentamicins; Haptoglobins; Male; Prednisolone; Stomatitis | 2018 |
In vitro binding of cefovecin to plasma proteins in Australian marsupials and plasma concentrations of cefovecin following single subcutaneous administration to koalas (Phascolarctos cinereus).
Topics: Animals; Anti-Bacterial Agents; Australia; Blood Proteins; Cephalosporins; Chromatography, High Pressure Liquid; Female; In Vitro Techniques; Injections, Subcutaneous; Male; Marsupialia; Phascolarctidae | 2019 |
Use of cefovecin in dogs and cats attending first-opinion veterinary practices in Australia.
Topics: Animals; Australia; Cat Diseases; Cats; Cephalosporins; Cross-Sectional Studies; Culture Techniques; Dog Diseases; Dogs; Female; Hospitals, Animal; Male; Microbial Sensitivity Tests | 2020 |
Cefovecin pharmacokinetics after single-dose intramuscular administration in cheetahs (Acinonyx jubatus).
Topics: Acinonyx; Animals; Anti-Bacterial Agents; Cephalosporins; Injections, Intramuscular | 2021 |
Divergent veterinarian and cat owner perspectives are barriers to reducing the use of cefovecin in cats.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Cephalosporins; Humans; Surveys and Questionnaires; Veterinarians | 2023 |